FIELD: chemistry; pharmaceuticals.
SUBSTANCE: invention relates to a compound of formula (I) or a pharmaceutically acceptable salt thereof, which has anticancer activity. The following is disclosed: a compound of formula (I) or a pharmaceutically acceptable salt thereof, as well as a pharmaceutical composition, drug and therapeutic agent based thereon for the treatment of diffuse large B-cell lymphoma (DLBCL). The use of the invention makes it possible to effectively treat diffuse large B-cell lymphoma (DLBCL). In the general formula (I), L1 and L2 are either the same or different and each represents a group represented by one formula selected from the group consisting of formulas (A) to (F), and S represents a group represented by one formula, selected from the group consisting of formulas (S1)–(S18).
EFFECT: obtaining a compound with anti-cancer activity.
20 cl, 18 tbl, 15 ex
| Title | Year | Author | Number |
|---|---|---|---|
| COMPOSITION OF TETRAHYDROQUINOLINES AS BROMODOMAIN BET MODIFYING AGENTS | 2014 |
|
RU2727169C2 |
| BETA-LACTAMASE INHIBITORS | 2009 |
|
RU2445314C9 |
| INHIBITION OF CREB-BINDING PROTEIN (CBP) | 2019 |
|
RU2803290C2 |
| PROTEOLYSIS MODULATORS AND RELATED USES | 2019 |
|
RU2805511C2 |
| POLYCYCLIC COMPOUNDS AND METHODS FOR TARGETED DEGRADATION OF POLYPEPTIDES OF FAST ACCELERATED FIBROSARCOMA | 2019 |
|
RU2830173C2 |
| NEW PYRROLOPYRIMIDINE COMPOUND OR ITS SALT, PHARMACEUTICAL COMPOSITION CONTAINING IT, IN PARTICULAR, AGENT FOR PREVENTION AND / OR TREATMENT OF TUMORS AND SO ON, BASED ON INHIBITING INFLUENCE ON NAE | 2015 |
|
RU2658008C2 |
| BIARYL DERIVATIVES AS INHIBITORS OF PROTEIN-PROTEIN INTERACTION YAP/TAZ-TEAD | 2021 |
|
RU2830596C1 |
| METHODS FOR PRODUCTION OF RACEMIC AMINOSUBSTITUTED 5,6,7,8-TETRAHYDROQUINOLINE OR RACEMIC AMINOSUBSTITUTED 5,6,7,8-TETRAHYDROISOQUINOLINE, METHODS FOR SEPARATION AND RACEMIZATION THEREOF, METHODS FOR PRODUCTION OF KETOSUBSTITUTED 5,6,7,8-TETRAHYDROQUINOLINE OR KETOSUBSTITUTED 5,6,7,8-TETRAHYDROISOQUINOLINE, METHOD FOR PRODUCTION OF ENANTIOMER PF CONDENSED BYCYCLIC RING SUBSTITUTED WITH PRIMARY AMINE, 5,6,7,8-TETRAHYDROQUINOLINE DERIVATIVES | 2002 |
|
RU2308451C2 |
| ANTITUMOUR EFFECT ENHANCER CONTAINING PYRROLOPYRIMIDINE COMPOUND | 2016 |
|
RU2710380C1 |
| SPLICEOSTATIN ANALOGS | 2013 |
|
RU2618523C2 |
